Additional Investment Sample Clauses
POPULAR SAMPLE Copied 1 times
Additional Investment. Beginning on the date hereof and ending on the one (1) year anniversary from the later of (i) the date a Registration Statement covering all Registrable Securities is declared effective or (ii) the date the Company has obtained Stockholder Approval, Buyer shall have the right, but not the obligation, at any time from time to time, in its sole and absolute discretion to purchase from the Company additional Convertible Notes (the “Additional Notes”) in an amount equal to an aggregate principal amount of $4,052,631.58 on the same terms and conditions as applicable to the purchase and sale of the Convertible Note in the principal amount of $2,105,263.16 purchased on the date hereof (each an “Additional Purchase” and collectively “Additional Purchases”). Buyer may exercise such right by the delivery of written notice to the Company, which notice shall include a statement that Buyer is exercising its right to cause the Additional Purchases, the principal amount of Convertible Notes to be purchased by Buyer, and the date on which such purchase and sale shall occur (“Additional Purchase Closing”), which Additional Purchase Closing shall occur within one (1) Trading Day following receipt of such notice by the Company, or such other date mutually agreed upon by the Buyer and the Company. The terms and conditions of any Additional Purchase shall be identical to the terms and conditions set forth in this Agreement applicable to the sale of the Convertible Notes; provided that the Maturity Date (as defined in the Convertible Notes) of the Convertible Notes shall be four (4) months from the issuance date of such Additional Notes. Further, upon each Additional Purchase, Buyer shall receive its proportional amount of warrants identical to the terms and conditions set forth in this Agreement (the “Additional Warrants”) provided that the Expiration Date (as defined in the Warrants) of the Additional Warrants shall be the fifth (5th) anniversary from the issuance date of such Additional Warrants. If Buyer elects to execute an Additional Purchase pursuant to this Section 4(k), the Company agrees and covenants that the restrictions applicable to Additional Registration Statements provided in Section 4(i) and Additional Issuances provided in Section 4(j) shall apply following the date on which the Additional Notes and Additional Warrants are delivered but only if the aggregate purchase price for such Additional Purchase is at least $1,000,000.
Additional Investment. The Investor commits to invest in additional Class A Shares or American depositary shares representing Class A Shares if and when the Company conducts an IPO, of an amount of no more than the Purchase Price. The Company and the lead underwriters shall have the right to accept or not accept such investment and, if so accepted, to determine whether to accept the investment as part of the IPO or as a private placement. Neither the Company nor any underwriter for the Company’s IPO is under any obligation or commitment to issue any shares to the Investor in the IPO. Any such issuance will be decided by the Company and the lead underwriters for the IPO and must be in compliance with all applicable laws, regulations and rules.
Additional Investment. (a) The Corporation shall have the right to issue and sell: (i) up to five million (5,000,000) additional Series A Shares at a price per share of not less than $1.00 and otherwise on terms no more favourable than the terms set forth in this Agreement; and (ii) any Series A Shares issuable upon the exercise of the EdgeStone Purchase Option pursuant to Section 3.2 (the issuance of the Series A Shares contemplated in clause (i) and (ii) together being referred to herein as the "Additional Investment").
(b) The Additional Investment shall be completed, in one or more closings, on such date or dates as may be selected by the Corporation; provided that, the last day on which any Series A Shares may be issued or sold pursuant to the Additional Investment shall be (A) August 31, 2004, or (B) such later date as may be agreed to in writing by the Corporation and EdgeStone (the applicable date in clause (A) or (B) above being hereinafter referred to as the "Expiry Date").
(c) Notwithstanding the foregoing, the Parties acknowledge and agree that: (i) the EdgeStone Purchase Option; (ii) the payment of the Lead Work Fee contemplated by Section 8.1; (iii) the reimbursement of Expenses contemplated by Section 8.2; and (iv) the entitlement to receive the EdgeStone Warrants are entitlements exclusive to EdgeStone as the lead investor with respect to the Investment, and shall not be extended to purchasers pursuant to the Additional Investment (except for EdgeStone and/or its permitted assignees on the exercise of the EdgeStone Purchase Option, to the extent provided in this Agreement) or to any purchasers of Common Shares as contemplated in Section 3.4.
Additional Investment. The Purchaser may (at its sole option) purchase additional notes from the Company in an aggregate principal amount of up to $40,000,000 pursuant to substantially similar documentation as this Agreement and the Related Agreements but in no event shall the Purchaser purchase any additional notes from Company at a time when an Event of Default (as defined in the Note) has occurred and is continuing.
Additional Investment. The Company agrees that the Purchaser shall have the right (at its sole option), on or prior to the date which is 270 days following the Closing Date, to issue an additional note to the Company in an aggregate principal amount of up to $2,000,000 on the same terms and conditions (including, without limitation, the same interest rate, the Fixed Conversion Price (as defined in the Note) then in effect, proportionate warrant coverage (at the same exercise prices), a proportionate amortization schedule, etc.) set forth in, and pursuant to substantially similar documentation as, this Agreement and the Related Agreements.
Additional Investment. The minimum principal amount equal to the purchase price of each additional Note is $10,000.
Additional Investment. The Investor commits to invest in additional B Shares or American depositary shares representing Shares if and when the Company conducts an IPO, of an amount of no more than the Purchase Price. The Company and the lead underwriters shall have the right to accept or not accept such investment and, if so accepted, to determine whether to accept the investment as part of the IPO or as a private placement. Neither the Company nor any underwriter for the Company’s IPO is under any obligation or commitment to issue any shares to the Investor in the IPO. Any such issuance will be decided by the Company and the lead underwriters for the IPO and must be in compliance with all applicable laws, regulations and rules.
Additional Investment. (a) Angiotech shall make an additional $5,000,000.00 investment in Athersys pursuant to the terms described in Section 2.3(b) within ten (10) business days after Athersys fulfills the first of the following conditions to occur (provided that if Athersys fulfills any such condition prior to January 1, 2007, then such condition shall be deemed to have been fulfilled on January 1, 2007):
(i) Athersys has commenced at least one additional pre-clinical animal study between the Effective Date and January 1, 2007 (in accordance with the applicable Pre-Clinical Development Plan) and either (A) such study has been completed prior to January 1, 2007 in accordance with the applicable pre-clinical animal study protocol; or (B) such study is ongoing as of January 1, 2007 and is being conducted in accordance with the applicable pre-clinical animal study protocol, or
(ii) at any time after January 1, 2007 Athersys completes at least one additional pre-clinical study (in accordance with the applicable Pre-Clinical Development Plan) in accordance with the applicable pre-clinical animal study protocol.
(b) With respect to the investment described in (a) above:
(i) if the Note has not been converted into capital stock of Athersys prior to the date of such investment, then Angiotech and Athersys shall enter into a note purchase agreement, in substantially the form of the Purchase Agreement, pursuant to which Angiotech shall loan $5,000,000.00 in cash to Athersys pursuant to a convertible promissory note having the same terms and conditions as the Note; and
(ii) if the Note has been converted into capital stock of Athersys prior to the date of such investment, then Angiotech and Athersys shall enter into a securities purchase agreement, in substantially the form of the Purchase Agreement (except for necessary adaptations for a securities purchase instead of a note purchase), pursuant to which Angiotech shall purchase with cash the number of whole shares of capital stock of Athersys that can be purchased with $5,000,000.00 in cash, at one hundred ten percent (110%) of the per share price at which stock is sold in the Bona Fide Financial Investment (as defined in the Note), on the terms and conditions set forth therein. The class and series of capital stock shall be the same as that sold in the Bona Fide Financial Investment.
Additional Investment. Prior to the termination of the Initial Public Offering, the Advisor agrees to purchase an additional amount of Shares at the then-current public offering price per Share, net of any Selling Commissions or Dealer Manager Fees, equal to the lesser of (a) 1% of the amount of Gross Proceeds raised from sales to persons who are not Affiliates of the Advisor in the Initial Public Offering or (b) $1,000,000.
Additional Investment. The business is looking for additional investment to assist in funding the start up of The Example Sandwich Company. We are currently looking for an investment of £10,000. We are currently also approaching the Bank and additional funding bodies in search of suitable grants.